The CEO's concentrated selling is notable but proportionally small relative to market cap. Without insider buying or a material corporate event, this cluster alone is unlikely to drive significant price action. Monitor for any follow-on Form 4 filings or a broader insider selling trend before reading this as a bearish signal.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 17 $597.12entry
- T+1 · 3mo ago −1.14%α −0.47% · $590.30
- T+5 · 3mo ago +3.84%α +5.03% · $620.03
- T+20 · 2mo ago +3.91%α +5.89% · $620.48
- T+60 · 7d ago +11.29%α +14.24% · $664.54
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Medpace CEO August Troendle sold $21.1M in stock over a 3-day window (Aug 10-12), with a director selling an additional $690K. This cluster of insider selling is significant in absolute dollar terms but represents only ~0.02% of Medpace's $13.6B market cap, making it proportionally trivial. The selling is concentrated in the CEO, which carries more weight, but the lack of any insider buying and the routine nature of the sales (open-market, not 10b5-1) suggests a neutral-to-slightly-bearish signal that is unlikely to move the stock on its own.
Key Financial Metrics
Key Facts
- CEO August Troendle sold 34,968 shares for ~$21.1M across three days (Aug 10-12)
- Director Cornelius McCarthy sold 1,140 shares for ~$690K on Aug 11
- Total insider selling of ~$21.8M represents ~0.16% of market cap
- No insider buying in the cluster window
- All sales were open-market transactions (not 10b5-1 plans)
Financial Impact
Total insider selling of ~$21.8M, or ~0.16% of Medpace's $13.6B market cap
Risk Factors
- CEO selling could indicate peak valuation concerns or personal liquidity needs
- Lack of insider buying suggests no strong conviction in near-term upside
- Cluster may be routine portfolio rebalancing given the small percentage of market cap
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MEDP-1786775083027 |
Track record
24 reports on MEDP
5 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +11.09% at T+20 after the Dec 4, 2025 report. 5 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $652.28 Now $648.20 +0.62% settles Nov 17
- Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $653.94 to $648.20 Now $648.20 −0.88% ▼ −0.88% +1.03% vs SPY
- Nov 2, 202614d ago Insider Cluster Bearish 4/10 Entry $663.49 to $656.77 Now $648.20 +2.30% ▲ +1.01% +2.66% vs SPY
- Oct 29, 202618d ago 144 Neutral 2/10 Entry $677.56 to $652.01 Now $648.20 −4.33% ▼ −3.77% −2.00% vs SPY
- Oct 27, 202620d ago 144 Neutral 2/10 Entry $673.79 to $692.68 Now $648.20 −3.80% ▲ +2.80% +2.46% vs SPY
- Oct 26, 202621d ago 144 Neutral 2/10 Entry $673.79 to $692.68 Now $648.20 −3.80% ▲ +2.80% +2.46% vs SPY
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $669.20 to $676.77 Now $648.20 −3.14% ▲ +1.13% +0.42% vs SPY
- Oct 21, 202626d ago 8-K Bullish 6/10 Entry $653.96 to $669.20 Now $648.20 −0.88% ▲ +2.33% +2.85% vs SPY
- Sep 28, 20267w ago SC 13D/A Neutral 4/10 Entry $622.11 to $624.18 Now $648.20 +4.19% ▲ +0.33% +0.54% vs SPY
- Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $583.21 to $593.02 Now $648.20 +11.14% ▲ +1.68% +1.24% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers